Analysen von Keyur Parekh
| 07.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.04.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.04.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 30.03.20 | Bayer buy | Goldman Sachs Group Inc. | |
| 30.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 24.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.03.20 | Sanofi buy | Goldman Sachs Group Inc. | |
| 17.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 16.03.20 | Bayer buy | Goldman Sachs Group Inc. | |
| 13.03.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.03.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.03.20 | Sanofi buy | Goldman Sachs Group Inc. | |
| 06.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 05.03.20 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 27.02.20 | Bayer buy | Goldman Sachs Group Inc. | |
| 25.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.02.20 | Roche buy | Goldman Sachs Group Inc. | |
| 18.02.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 06.02.20 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 06.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.02.20 | GSK buy | Goldman Sachs Group Inc. | |
| 05.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 30.01.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.01.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 27.01.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 24.01.20 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 24.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 24.01.20 | Bayer buy | Goldman Sachs Group Inc. | |
| 23.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 23.01.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 22.01.20 | Bayer buy | Goldman Sachs Group Inc. | |
| 22.01.20 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 22.01.20 | Bayer buy | Goldman Sachs Group Inc. | |
| 20.01.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 20.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.12.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.12.19 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 09.12.19 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 06.12.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.12.19 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 25.11.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 21.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.11.19 | Bayer buy | Goldman Sachs Group Inc. | |
| 18.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.11.19 | Roche buy | Goldman Sachs Group Inc. | |
| 06.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |